35
10
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4965 |
TCS-OX2-29
|
OX Receptor | GPCR/G Protein; Neuroscience |
TCS-OX2-29 是高亲和力和选择性OX2R 拮抗剂,IC50值为 40 nM,pKI 值为 7.5。它对 OX2 的选择性比 OX1 高 250 倍以上。 | |||
T4965L |
TCS-OX2-29 HCl
TCSOX 229,TCS-OX229,TCS OX229,TCS OX2 29,TCSOX-229,TCSOX229 |
||
TCS-OX2-29 is a selective orexin-2 receptor antagonist (IC50 = 40 nM), which plays an important role in pain modulation. | |||
T1823 |
IOX2
IOX 2,JICL38 |
HIF/HIF Prolyl-Hydroxylase | Chromatin/Epigenetic; Metabolism |
IOX2 (IOX 2) 是特异性的脯氨酰羟化酶-2 抑制剂,IC50=22 nM。 | |||
T82630 |
CysOx2
|
||
CysOx2为磺胺酸反应基荧光探针(Ex/Em: 394/535nm),专用于检测活细胞内蛋白质半胱氨酸氧化情况。 | |||
T62855 |
OX2R-IN-1
|
||
OX2R-IN-1 是一种 OX2R 拮抗剂 (一种潜在的 OX2R 结合剂),表现出低细胞毒性 (IC50: 484 μM)。OX2R-IN-1 具有血脑屏障通透性,药物半衰期短。 | |||
T81647 |
NOX2-IN-2
|
||
NOX2-IN-2(化合物33)作为一种高效的NOX2抑制剂,其作用机制是针对p47phox-p22phox的蛋白-蛋白相互作用,具有0.24 μM的Ki值。该化合物能够抑制NOX2在细胞内产生的ROS。 | |||
T81648 |
NOX2-IN-1
|
||
NOX2-IN-1 是 NOX2 (烟酰胺腺嘌呤二核苷酸磷酸氧化酶异构体 2) 的抑制剂。该化合物旨在针对 p47phox-p22phox 蛋白间相互作用,展现出优秀的结合亲和力及细胞活性。 | |||
T2710 |
TCS 1102
|
OX Receptor | GPCR/G Protein; Neuroscience |
TCS 1102 是双食欲素受体拮抗剂,对 OX1和OX2受体的Ki 分别为3和 0.2 nM。 | |||
T5498 |
SB-649868
GSK649868 |
OX Receptor | GPCR/G Protein; Neuroscience |
SB-649868 (GSK649868) 是一种有效的选择性口服活性食欲素拮抗剂,对 OX1 和 OX2 受体的 pKi 分别为 9.4 和 9.5。 | |||
T5503 |
IPSU
|
OX Receptor | GPCR/G Protein; Neuroscience |
IPSU 是可口服和脑渗透性的选择性OX2R 拮抗剂,pKi 值为7.85。 | |||
T2613 |
Almorexant
阿莫伦特,ACT 078573 |
OX Receptor | GPCR/G Protein; Neuroscience |
Almorexant (ACT 078573) 是一种有效的竞争性食欲素 1 受体 (OX1)/食欲素 2 受体 (OX2) 双重拮抗剂,OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。 | |||
TP1045L |
Orexin B, rat, mouse Acetate
Rat orexin B,Orexin B (mouse) Acetate,Orexin B, rat, mouse Acetate(202801-92-1 free base) |
OX Receptor | GPCR/G Protein; Neuroscience |
Orexin B, rat, mouse Acetate (Rat orexin B)(202801-92-1 free base) 是 Orexin 受体的内源性激动剂,对 OX1 和 OX2 的 Kis 分别为 420 和 36 nM。 | |||
TP1973L |
OXA (17-33) acetate
|
OX Receptor | GPCR/G Protein; Neuroscience |
OXA (17-33) acetate 是一种比 OX2 (EC50 = 187 nM) 更有效的 orexin-1 受体 (OX1, EC50 = 8.29 nM)) 激动剂。 | |||
T1913 |
MK-3697
|
OX Receptor | GPCR/G Protein; Neuroscience |
MK3697是OX2受体的一种高效选择性拮抗剂,Ki 值为0.95nM。 | |||
T11186 |
EMPA
|
OX Receptor | GPCR/G Protein; Neuroscience |
EMPA 是一种选择性、高亲和力和可逆的食欲素 OX2 受体拮抗剂,与人和大鼠 OX2-HEK293 膜结合,KD 值分别为 1.1 和 1.4 nM。 | |||
TP1975L |
[Ala11,D-Leu15]-Orexin B acetate
[Ala11,D-Leu15]-Orexin B acetate (532932-99-3 Free base) |
OX Receptor | GPCR/G Protein; Neuroscience |
[Ala11,D-Leu15]-Orexin B acetate 是一种特异性 orexin-2 受体 (OX2) 激动剂,EC50 为 0.13 nM,比 OX1 (52 nM) 特异性高 400 倍。 | |||
T16854 |
SB-674042
SB674042 |
OX Receptor | GPCR/G Protein; Neuroscience |
SB-674042 是一种具有高效性和选择性的非肽类食欲肽 OX1和 OX2 受体双重拮抗剂, IC50 分别为 3.76 nM 和 531 nM。SB-674042 可用于治疗抑郁症 。 | |||
T16096 |
Filorexant
MK-6096 |
OX Receptor | GPCR/G Protein; Neuroscience |
Filorexant (MK-6096) 是一种口服有效且选择性可逆的 OX1 和 OX2 受体拮抗剂,Ki 值小于3nM。 | |||
T6658 |
SB-408124
N-(6,8-二氟-2-甲基-4-喹啉)- N-[4-(二甲氨基)苯基]尿素 |
OX Receptor | GPCR/G Protein; Neuroscience |
SB408124 是一种 OX1 受体的非肽拮抗剂,在全细胞和膜中的 Ki 值分别为 57 和 27 nM,其选择性是 OX2 受体的 50 倍。 | |||
T6140 |
SB-334867 free base
SB334867A free base,SB-334867,SB 334867,SB334867 |
OX Receptor | GPCR/G Protein; Neuroscience |
SB-334867 free base (SB334867A free base) 是一种选择性 orexin-1(OX1) 受体拮抗剂,对 OX2有选择性,pKb 为7.4,对 5-HT2B、5-HT2C 的选择性是 100 倍,pKi 值分别为 5.4 和 5.3。它减少乙醇消耗,还抑制吗啡诱导的体内运动活动敏感性的获得。 | |||
T39229 |
YNT-185
|
OX Receptor | GPCR/G Protein; Neuroscience |
YNT-185 是一种非肽类、选择性的俄睾丸激素2型受体(OX2R)激动剂,对 OX2 R和 OX1R 的 EC50 值分别为 0.028 μM 和 2.75 μM。此外,YNT-185 在小鼠模型中有效缓解了嗜睡症-猝倒症的症状。 | |||
T12877L |
Seltorexant
JNJ-42847922 |
OX Receptor | GPCR/G Protein; Neuroscience |
Seltorexant (JNJ-42847922) 是一种可口服,高亲和性以及选择性的 orexin-2 受体(OX2R)拮抗剂,对人和大鼠中的 OX2R 的pKi 值分别为 8.0 和 8.1。它穿过血脑屏障,迅速占据大鼠大脑中的 OX2R 结合位点。 | |||
T6155 |
Almorexant hydrochloride
ACT-078573 hydrochloride,Almorexant HCl |
OX Receptor | GPCR/G Protein; Neuroscience |
Almorexant hydrochloride (ACT-078573 hydrochloride) 是一种有效的竞争性食欲素 1 受体(OX1)/食欲素 2 受体 (OX2) 双重拮抗剂,OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。 | |||
T37112 |
YNT-185 dihydrochloride
|
||
Potent and selective orexin OX2 receptor agonist (EC50 = 28 nM at human OX2 expressed in CHO cells). Displays approximately 100-fold selectivity for OX2 over OX1 (EC50 = 2.75 μM at human OX1 expressed in CHO cells). Depolarizes OX2-expressing histaminergic neurons in mouse brain slices. Increases wake time in wild type mice. Suppresses cataplexy-like symptoms in OX knockout mice. Nagahara et al (2015) Design and synthesis of non-peptide, selective orexin receptor 2 agonists. J.Med.Chem. 58 7931 ... | |||
T75921 |
[Ala11,D-Leu15]-Orexin B(human) TFA
|
||
[Ala11,D-Leu15]-Orexin B(human) TFA为高效的orexin-2 receptor (OX2)选择性激动剂。其对OX2展现出比OX1 (52 nM) 高达400倍的较高选择性(EC50=0.13 nM)。 | |||
T22880 |
JNJ-10397049
JNJ 10397049 |
Others | Others |
OX2 receptor antagonist | |||
TP1138 |
Orexin B, human TFA (205640-91-1 free base)
Orexin B, human TFA,Human orexin B TFA |
||
Orexin B, human (TFA) is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2. | |||
TP1975 |
[Ala11,D-Leu15]-Orexin B(human)
[Ala11,D-Leu15]-Orexin B |
||
Highly potent and selective OX2 receptor agonist; displays 400-fold selectivity over OX1 receptors. EC50 values are 0.13 and 52 nM for human OX2 and OX1 receptors respectively. | |||
T75922 |
OXA(17-33) TFA
|
||
OXA(17-33) TFA,一种高效且选择性的orexin-1 receptor (OX1)激动剂,其对OX1 (EC50=8.29 nM) 的选择性是对OX2 (187 nM) 的23倍。 | |||
T75920 |
Orexin B, human TFA
|
||
Orexin B, human (TFA) 是 Orexin 受体的内源性激动剂,与 OX1和 OX2结合的 Ki 值分别为 420 和 36 nM。 | |||
TP1139 |
Orexin B, human
Human orexin B |
||
Orexin B, human is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively. Orexin B is a hypothalamatic neuropeptide stimulating food intake in rats. | |||
TP1045 |
Orexin B, rat, mouse
Orexin B (mouse),Rat orexin B |
||
Orexin B, rat, mouse is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively. | |||
TP1550 |
Orexin A (human, rat, mouse) (TFA)
|
||
Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions. | |||
TP1973 |
OXA(17-33)
OXA (17-33) |
||
Potent and selective peptide orexin OX1 receptor agonist (EC50 values are 8.29 and 187 nM for OX1 and OX2 receptors respectively). Truncated form of orexin A. | |||
T75925 |
Orexin B, rat, mouse TFA
|
||
Orexin B, rat, mouse (Rat orexin B) TFA,作为一种内源性促进食欲的(Orexin receptor)激动剂,通过结合并激活两个亲密相关的孤儿G蛋白偶联受体OX1-R和OX2-R,促进食物摄入和能量消耗,并在睡眠-觉醒调节中扮演关键角色。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05446 |
CD200 Protein, Human, Recombinant (hFc)
MOX1,Cd200 molecule,MRC,OX2 |
Human | HEK293 Cells |
CD200 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.2 kDa and the accession number is A0A2R9ADU6. | |||
TMPY-01160 |
CD200 Protein, Mouse, Recombinant (His)
Cd200 molecule,OX2,Mox |
Mouse | HEK293 Cells |
CD200 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is O54901.1. | |||
TMPY-05638 |
CD200 Protein, Human, Recombinant (hFc & Avi)
MRC,MOX2,Cd200 molecule,OX |
Human | HEK293 Cells |
CD200 Protein, Human, Recombinant (hFc & Avi) is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 51 kDa and the accession number is P41217-2. | |||
TMPY-06791 |
CD200 Protein, Human, Recombinant (His & Avi), Biotinylated
MOX2,Cd200 molecule,OX |
Human | HEK293 Cells |
CD200 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 25.71 kDa and the accession number is NP_005935.4. | |||
TMPK-00476 |
CD200 Protein, Cynomolgus, Recombinant (His)
MOX1,CD200,MOX2,My033, |
Cynomolgus | HEK293 Cells |
CD200 and its receptors are highly expressed in the lung, on epithelial cells and leukocytes, and emerging evidence links dysregulation of the CD200 pathway with asthma. Moreover, pharmacological modulation of CD200 receptors was shown to improve clinical and inflammatory outcomes of preclinical asthma models. CD200 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 23.66 kDa and the accession number is A0A2K5TQS2. | |||
TMPK-00733 |
CD200 Protein, Mouse, Recombinant (aa 31-232, His)
My033,OX2,MRC,OX-2,M... |
Mouse | HEK293 Cells |
CD200 and its receptors are highly expressed in the lung, on epithelial cells and leukocytes, and emerging evidence links dysregulation of the CD200 pathway with asthma. Moreover, pharmacological modulation of CD200 receptors was shown to improve clinical and inflammatory outcomes of preclinical asthma models. CD200 Protein, Mouse, Recombinant (aa 31-232, His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 23.6 kDa and the accession number is O54901. | |||
TMPY-01071 |
CD200 Protein, Human, Recombinant (His)
Cd200 molecule,MOX2,OX |
Human | HEK293 Cells |
CD200 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is P41217-2. | |||
TMPJ-00233 |
CD200R1/CRTR2 Protein, Human, Recombinant (His)
Cell Surface Glycoprotein CD200 Receptor 1,OX |
Human | HEK293 Cells |
Cell surface glycoprotein CD200 Receptor 1 (CD200R1) is the receptor for the CD200 (OX-2) membrane glycoprotein. CD200R1 contains one C2- type Ig-like domain and one V-type Ig-like domain within its extracellular domain and a PTB-signaling motif in cytoplasmic domain. CD200R1 and CD200 associate via their respective N-terminal Ig-like domains. CD200R1 is restricted primarily to mast cells, basophils, macrophages, and dendritic cells. It propagates inhibitory signals despite its lacking a cytopla... | |||
TMPH-01278 |
ENOX2 Protein, Human, Recombinant (His & Myc)
Cytosolic ovarian carcinoma antigen 1,Ecto-NOX disu... |
Human | E. coli |
May be involved in cell growth. Probably acts as a terminal oxidase of plasma electron transport from cytosolic NAD(P)H via hydroquinones to acceptors at the cell surface. Hydroquinone oxidase activity alternates with a protein disulfide-thiol interchange/oxidoreductase activity which may control physical membrane displacements associated with vesicle budding or cell enlargement. The activities oscillate with a period length of 22 minutes and play a role in control of the ultradian cellular biol... | |||
TMPH-01277 |
ENOX2 Protein, Human, Recombinant
ENOX2,APK1 antigen,Cytosolic ovarian carci... |
Human | E. coli |
May be involved in cell growth. Probably acts as a terminal oxidase of plasma electron transport from cytosolic NAD(P)H via hydroquinones to acceptors at the cell surface. Hydroquinone oxidase activity alternates with a protein disulfide-thiol interchange/oxidoreductase activity which may control physical membrane displacements associated with vesicle budding or cell enlargement. The activities oscillate with a period length of 22 minutes and play a role in control of the ultradian cellular biol... |